NEW YORK (GenomeWeb News) – Arrayit said today that it has won a competitive contract from the Centers for Disease Control and Prevention for use of the company's microarray platform for biothreat response technologies.

The CDC will use the Arrayit microarray manufacturing platform to create microarrays for use in combating infectious agents, such as viruses and bacteria, which could be used in terrorist attacks.

Financial terms of the contract were not released.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The Union of Concerned Scientists surveyed US government scientists about Trump Administration policies and more, Science reports.

National Geographic reports that marine mammals have lost a gene that could make them more susceptible to organophosphate damage.

NPR reports on Human Cell Atlas Consortium's effort to catalog all the different cell types within the human body.

In PNAS this week: history and genetic diversity of the scarlet macaw, approach for predicting human flu virus evolution, and more.